PHARMACOKINETICS OF UNLABELED AND C-14-LABELED PINDOLOL IN UREMIA

被引:39
作者
OHNHAUS, EE
NUESCH, E
MEIER, J
KALBERER, F
机构
[1] SANDOZ LTD,BIOL & MED RES DIV,EXPTL THERAPEUTICS DEPT,BASEL,SWITZERLAND
[2] SANDOZ LTD,BIOPHARM SECT,BASEL,SWITZERLAND
关键词
D O I
10.1007/BF00614386
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:25 / 29
页数:5
相关论文
共 9 条
[1]   SERUM CREATININE DETERMINATION WITHOUT PROTEIN PRECIPITATION [J].
BARTELS, H ;
BOHMER, M ;
HEIERLI, C .
CLINICA CHIMICA ACTA, 1972, 37 (NMAR) :193-&
[2]   THE PATHOLOGIC PHYSIOLOGY OF CHRONIC BRIGHTS DISEASE - AN EXPOSITION OF THE INTACT NEPHRON HYPOTHESIS [J].
BRICKER, NS ;
MORRIN, PAF ;
KIME, SW .
AMERICAN JOURNAL OF MEDICINE, 1960, 28 (01) :77-98
[3]  
DETTLI L, 1971, ACTA PHARMACOL TOX, V29, P211
[4]  
MANNHART M, 1971, SCHWEIZ MED WSCHR, V101, P123
[5]   A METHOD FOR FLUORIMETRIC DETERMINATION OF 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)-INDOLE (LB46), A BETA-BLOCKING AGENT, IN PLASMA AND URINE [J].
PACHA, WL .
EXPERIENTIA, 1969, 25 (08) :802-&
[6]  
SCHWARZ HJ, 1970, UNPUBLISHED REPORT
[7]   PHARMACODYNAMICS OF PROPRANOLOL IN RENAL-FAILURE [J].
THOMPSON, FD ;
JOEKES, AM ;
FOULKES, DM .
BRITISH MEDICAL JOURNAL, 1972, 2 (5811) :434-&
[8]  
TRAEGER A, 1972, INT J CLIN PHARM TH, V6, P237
[9]  
WAGNER H, 1970, UNPUBLISHED REPORT